SCHEDULE OF SEGMENT REVENUE (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
SegmentReportingLineItems [Line Items]
Revenues	$ 8,979	$ 7,009
Cost of Revenues:
Material and Labor	5,200	4,698
Other cost of revenues	1,130	805
Total Cost of revenues	6,330	5,503
Research and development (R&D)
Share based compensation	12,332	10,138
Total Research and development	15,003	13,634
Selling and marketing (S&M)
Total Selling and marketing	16,553	6,069
General and administrative (G&A)
Total General and administrative	20,707	15,306
Financial Income, net;	891	1,557
Tax Expenses	63	59
NET LOSS	(48,786)	(32,005)
Research and Development Expenses [Member]
Research and development (R&D)
Payroll and Benefits	4,052	2,858
Share based compensation	2,559	2,412
Clinical trials	4,488	3,815
Other R&D	3,904	4,549
Selling and Marketing Expenses [Member]
Research and development (R&D)
Payroll and Benefits	11,346	3,769
Share based compensation	1,888	1,025
Selling and marketing (S&M)
Other S&M	3,319	1,275
General and Administrative Expenses [Member]
Research and development (R&D)
Payroll and Benefits	6,650	4,221
Share based compensation	7,667	6,445
General and administrative (G&A)
Other G&A	$ 6,390	$ 4,640